A team of scientists at The University of Texas Medical Branch (UTMB), led by Nikos Vasilakis, Ph.D., and Peter McCaffrey, MD ...
The wave-shaped chart Ratul Chowdhury pulls up on a computer monitor in his office captures the evolutionary cat-and-mouse ...
Before the pandemic, roughly half of counties had kindergarten vaccination rates high enough to prevent measles outbreaks. After the pandemic, many counties increased their vaccination rates, reaching ...
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...
Over the last 30 years, scientists have experimented with ways to harness plant biology to create medications, or even deliver vaccines to animals and humans — but the science has moved away from ...
It's an anniversary no one wants to celebrate, but an anniversary nonetheless. Thursday, March 19, marked six years since the first COVID-19 lockdown was implemented in the United States. And while it ...
Four doses of an experimental vaccine to protect against Lyme disease reduced the number of tick-borne infections by more than 70 percent, according to Pfizer and Valneva, the pharmaceutical companies ...
A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the ...
Matthew Herper covers medical innovation — both its promise and its perils. An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to ...
Health Secretary Robert F. Kennedy Jr.’s vaccine skepticism is posing challenges for the Trump administration. Top health jobs are unfilled, and a court has blocked his vaccine schedule changes. By ...
Pfizer and Valneva said Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its main goal. Subscribe to read this story ad-free Get unlimited ...
Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results